BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8377656)

  • 1. Mutagenic processing of psoralen monoadducts differ in normal and Fanconi anemia cells.
    Guillouf C; Laquerbe A; Moustacchi E; Papadopoulo D
    Mutagenesis; 1993 Jul; 8(4):355-61. PubMed ID: 8377656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutagenic processing of psoralen photolesions leaves a highly specific signature at an endogenous human locus.
    Laquerbe A; Guillouf C; Moustacchi E; Papadopoulo D
    J Mol Biol; 1995 Nov; 254(1):38-49. PubMed ID: 7473757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular spectrum of mutations induced at the HPRT locus by a cross-linking agent in human cell lines with different repair capacities.
    Papadopoulo D; Laquerbe A; Guillouf C; Moustacchi E
    Mutat Res; 1993 Aug; 294(2):167-77. PubMed ID: 7687009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular mechanism underlying formation of deletions in Fanconi anemia cells may involve a site-specific recombination.
    Laquerbe A; Moustacchi E; Fuscoe JC; Papadopoulo D
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):831-5. PubMed ID: 7846061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus.
    Papadopoulo D; Guillouf C; Mohrenweiser H; Moustacchi E
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8383-7. PubMed ID: 2236046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients.
    Laquerbe A; Sala-Trepat M; Vives C; Escarceller M; Papadopoulo D
    Mutat Res; 1999 Dec; 431(2):341-50. PubMed ID: 10635999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links.
    Kumaresan KR; Lambert MW
    Carcinogenesis; 2000 Apr; 21(4):741-51. PubMed ID: 10753211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPRT gene expression differs in mutants derived from normal and Fanconi anemia cells: analysis of spontaneous and psoralen-photoinduced mutants.
    Guillouf C; Moustacchi E; Papadopoulo D
    Somat Cell Mol Genet; 1991 Nov; 17(6):591-9. PubMed ID: 1685031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repair of 4,5',8-trimethylpsoralen plus light-induced DNA damage in normal and Fanconi's anemia cell lines.
    Averbeck D; Papadopoulo D; Moustacchi E
    Cancer Res; 1988 Apr; 48(8):2015-20. PubMed ID: 3349473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of spontaneously occurring mutations in the HPRT gene of the Chinese hamster V79 cell mutant V-H4, which is homologous to Fanconi anemia group A.
    Telleman P; Overkamp WJ; Zdzienicka MZ
    Mutagenesis; 1996 Mar; 11(2):155-9. PubMed ID: 8671732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of point mutations in the coding region of the hypoxanthine-guanine phosphoribosyltransferase (hprt) gene in human T-lymphocytes in vivo.
    Podlutsky A; Osterholm AM; Hou SM; Hofmaier A; Lambert B
    Carcinogenesis; 1998 Apr; 19(4):557-66. PubMed ID: 9600338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxic potential of psoralen cross-links versus monoadducts in normal human lymphoblasts.
    Laquerbe A; Moustacchi E; Papadopoulo D
    Mutat Res; 1995 Mar; 346(3):173-9. PubMed ID: 7700281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity and specific mutation spectrum induced by 8-methoxypsoralen plus a low dose of UVA in the hprt gene in diploid human fibroblasts.
    Chiou CC; Yang JL
    Carcinogenesis; 1995 Jun; 16(6):1357-62. PubMed ID: 7788855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strand-specific mutation induction by 1,2-dibromomethane at the hypoxanthine-guanine phosphoribosyltransferase locus of Chinese hamster ovary cells.
    Ballering LA; Vogel EW; Vrieling H; Nivard MJ
    Mutagenesis; 1998 Jan; 13(1):61-5. PubMed ID: 9491396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fanconi anemia polypeptide FACC is localized to the cytoplasm.
    Yamashita T; Barber DL; Zhu Y; Wu N; D'Andrea AD
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6712-6. PubMed ID: 7517562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fanconi anemia pathway limits the severity of mutagenesis.
    Hinz JM; Nham PB; Salazar EP; Thompson LH
    DNA Repair (Amst); 2006 Aug; 5(8):875-84. PubMed ID: 16815103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequencies of HPRT- lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors.
    Sala-Trepat M; Boyse J; Richard P; Papadopoulo D; Moustacchi E
    Mutat Res; 1993 Sep; 289(1):115-26. PubMed ID: 7689157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational response of Fanconi anaemia cells to shuttle vector site-specific psoralen cross-links.
    Bredberg A; Sandor Z; Brant M
    Carcinogenesis; 1995 Mar; 16(3):555-61. PubMed ID: 7697813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic response of Fanconi's anemia cells from a defined complementation group after treatment with photoactivated bifunctional psoralens.
    Papadopoulo D; Porfirio B; Moustacchi E
    Cancer Res; 1990 Jun; 50(11):3289-94. PubMed ID: 2159378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of mutations in phenotypic variants of hypoxanthine phosphoribosyltransferase deficiency.
    Sege-Peterson K; Chambers J; Page T; Jones OW; Nyhan WL
    Hum Mol Genet; 1992 Sep; 1(6):427-32. PubMed ID: 1301916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.